These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 14703580

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Expensive modern therapy options in intensive care medicine in Germany-- are they being used? Results of a questionnaire].
    Boldt J, Papsdorf M.
    Dtsch Med Wochenschr; 2005 Jan 21; 130(3):87-91. PubMed ID: 15650957
    [Abstract] [Full Text] [Related]

  • 3. [Cost analysis concerning MRSA-infection in ICU].
    Geldner G, Ruoff M, Hoffmann HJ, Kiefer P, Georgieff M, Wiedeck H.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jul 21; 34(7):409-13. PubMed ID: 10464519
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D, Nyc O, Pokorný D, Landor I, Sosna A.
    Acta Chir Orthop Traumatol Cech; 2006 Oct 21; 73(5):329-33. PubMed ID: 17140514
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Methicillin-resistant Staphylococcus aureus nosocomial infections in ICU: risk factors, morbidity and cost].
    Lepelletier D, Ferréol S, Villers D, Richet H.
    Pathol Biol (Paris); 2004 Oct 21; 52(8):474-9. PubMed ID: 15465267
    [Abstract] [Full Text] [Related]

  • 9. [Economic aspects of intensive care medicine--cost and reimbursement according to diagnosis related grouping].
    Billing A, Thalhammer M, Eissner HJ, Jauch KW, Inthorn D.
    Zentralbl Chir; 2004 Dec 21; 129(6):440-6. PubMed ID: 15616906
    [Abstract] [Full Text] [Related]

  • 10. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD, Salgado CD, Durkalski VL, Bosso JA.
    Ann Pharmacother; 2008 Mar 21; 42(3):317-26. PubMed ID: 18285560
    [Abstract] [Full Text] [Related]

  • 11. Clinical imperative versus economic consequence: exploring the cost burden and opportunities in the care of patients with sepsis.
    Merritt CL.
    Nurs Adm Q; 2011 Mar 21; 35(1):61-7. PubMed ID: 21157265
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Staphylococcal infections as an important problem in intensive therapy--own clinical observations].
    Czaban SL, Olszańska D, Siemiatkowski A.
    Przegl Lek; 2006 Mar 21; 63(7):529-32. PubMed ID: 17203802
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Calculation of costs per inpatient day in an intensive care unit].
    Alvear V S, Canteros J, Rodríguez P.
    Rev Med Chil; 2010 May 21; 138(5):558-66. PubMed ID: 20668810
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effectiveness and efficiency of intensive care medicine: variable costs in different diagnosis groups.
    Iapichino G, Radrizzani D, Simini B, Rossi C, Albicini M, Ferla L, Colombo A, Pezzi A, Brazzi L, Melotti R, Rossi G, Italian Group for the Evaluation of Interventions in Intensive Care Medicine.
    Acta Anaesthesiol Scand; 2004 Aug 21; 48(7):820-6. PubMed ID: 15242425
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.